The study compared the European Union system for biosimilar introduction to that of the United States and evaluated the savings that would have arisen from the presence of multiple biosimilars of Humira.
NCPA, NACDS, and WSPA are hailing a move by the Department of Justice that could signal victory in their case against low Medicaid reimbursements for pharmacies.
NACDS has filed an amicus brief with the 8th U.S. Circuit Court of Appeals supporting North Dakota's law regulating PBMs and pointing to recent precedent from the Supreme Court to inform the appeals court's ruling.
National Community Pharmacists Association CEO Doug Hoey, in a roundtable discussion with Health and Human Services Secretary Xavier Becerra, focused on four major priorities for independent pharmacies.
The National Association of Chain Drug Stores is praising three legislative victories in Iowa that empower pharmacists to focus their time on patients and clinical care, and extend Iowans’ access to routine vaccinations and point-of-care testing.
The new law prioritizes patient health and patient access, protecting Texans’ ability to receive pharmacy services from their chosen pharmacy provider.
Sun Pharma will be able to manufacture and sell a limited quantity of generic lenalidomide capsules after March 2022, as well as an unlimited quantity beginning Jan. 31, 2026.
